UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
FEBS letters, ISSN 0014-5793, 2006, Volume 580, Issue 12, pp. 2896 - 2902
Virus infection | Virus–host interaction | RNA interference | TAR | hepatitis B virus | virus-associated RNA II | IFN dsRNA | small interfering RNA | double-stranded RNA | HRV-16 | cytomegalovirus | micro RNA | shRNA | short hairpin RNA | SIRCT | HBV | dsRNA | RNAi | Kaposi's sarcoma-associated virus | VA-RNAI | dengue virus | SARS | HSV | TAR RNA binding protein | CMV | RSV | AAV | human papillomavirus | human immunodeficiency virus | SV40 | VSV | pre-miRNA | HCV | simian virus 40 | JCV | respiratory syncytial virus | IFN-PKR | human rhinovirus-16 | vesicular stomatitis virus | adeno-associated virus | Epstein Barr virus | PFV-1 | HPV | severe acute respiratory syndrome | VA-RNAII | herpes simplex virus | precursor miRNA | interferon-induced protein kinase R | KSHV | EBV | hepatitis C virus | murine hepatitis virus 6 | miRNA | HDV | interferon-induced dsRNA | hepatitis delta virus | MHV6 | RISC | siRNA | RNA-induced silencing complex | TRBP | DEN | siRNA combination therapy | primate foamy virus type 1 | trans-activating response region | HIV | JC virus | virus-associated RNA I | Virus-host interaction | Biochemistry & Molecular Biology | Biophysics | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Hepacivirus - physiology | Virus Inactivation | Animals | RNA Interference | Humans | RNA, Messenger - physiology | Proteins | Hepatitis | RNA | HIV (Viruses) | Gene expression | Papillomavirus infections | Health aspects | Protein binding | Index Medicus | HBV, hepatitis B virus | DEN, dengue virus | RNAi, RNA interference | JCV, JC virus | dsRNA, double-stranded RNA | HCV, hepatitis C virus | EBV, Epstein Barr virus | HDV, hepatitis delta virus | KSHV, Kaposi’s sarcoma-associated virus | MHV6, murine hepatitis virus 6 | miRNA, micro RNA | pre-miRNA, precursor miRNA | AAV, adeno-associated virus | SIRCT, siRNA combination therapy | HSV, herpes simplex virus | RISC, RNA-induced silencing complex | VA-RNAII, virus-associated RNA II | VA-RNAI, virus-associated RNA I | IFN dsRNA, interferon-induced dsRNA | SV40, simian virus 40 | IFN-PKR, interferon-induced protein kinase R | HIV, human immunodeficiency virus | PFV-1, primate foamy virus type 1 | VSV, vesicular stomatitis virus | SARS, severe acute respiratory syndrome | TRBP, TAR RNA binding protein | HPV, human papillomavirus | HRV-16, human rhinovirus-16 | siRNA, small interfering RNA | TAR, trans-activating response region | CMV, cytomegalovirus | shRNA, short hairpin RNA | RSV, respiratory syncytial virus
Journal Article
ACS chemical neuroscience, ISSN 1948-7193, 04/2020, Volume 11, Issue 7, pp. 995 - 998
Biochemistry & Molecular Biology | Neurosciences | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Neurosciences & Neurology | Chemistry, Medicinal | Science & Technology | Pandemics | Receptors, Virus - metabolism | Humans | Coronavirus Infections - physiopathology | Peptidyl-Dipeptidase A | Coronavirus Infections - immunology | Pneumonia, Viral - immunology | Pneumonia, Viral - physiopathology | COVID-19 | Host-Pathogen Interactions | Tissue Distribution | Angiotensin-Converting Enzyme 2 | SARS-CoV-2 | Betacoronavirus - physiology | Central Nervous System - physiopathology | Central Nervous System - virology | Index Medicus
Journal Article
Journal of molecular biology, ISSN 0022-2836, 09/2018, Volume 430, Issue 19, pp. 3481 - 3503
viruses | Cell polarity | Life Sciences & Biomedicine | Biochemistry & Molecular Biology | Science & Technology | Humans | Cell Polarity - physiology | Virus Physiological Phenomena | Oncogenic Viruses - physiology | Organ Specificity | Immunity | Host-Pathogen Interactions - immunology | Encephalitis | Sarcoma | Severe acute respiratory syndrome | Dengue viruses | Proteins | Hepatitis | Adenoviruses | Measles | Stem cells | West Nile fever | Hepatitis C virus | Health aspects | Papillomavirus infections | Index Medicus | CAR, coxsackie and adenovirus receptor | HBV, hepatitis B virus | WNV, West Nile virus | MCP, migrating cell polarity | VZV, varicella zoster virus | HCV, hepatitis C virus | AdV, adenovirus | MV, measles virus | KSHV, Kaposi's sarcoma herpesvirus | HTLV-1, human T lymphotrophic virus-1 | Scrib, Scribble | MuV, mumps virus | HSV, herpes simplex virus | AJs, adherens junctions | ICP, immune cell polarity | TJs, tight junctions | Par, Partitioning defective | PBM, PDZ-binding motif | IAV, Influenza A virus | EMT, epithelial-to-mesenchymal transition | ABP, apico-basal polarity | SARS, severe acute respiratory syndrome | Dlg1, Discs Large 1 | TBEV, tick-borne encephalitis virus | PCP, planar cell polarity | HPV, human papillomavirus | MCPyV, Merkel cell polyoma virus | RaV, rabies virus | EBV, Epstein–Barr virus | CMV, cytomegalovirus | HCC, hepatocellular carcinoma | HIV-1, human immunodeficiency virus-1 | DENV, Dengue virus
Journal Article
Nature communications, ISSN 2041-1723, 12/2020, Volume 11, Issue 1, pp. 1620 - 1620
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Broadly Neutralizing Antibodies - immunology | SARS Virus - immunology | Pandemics | Calcium Channels - metabolism | Receptors, Virus - metabolism | Humans | Protein Multimerization | Severe Acute Respiratory Syndrome - immunology | Neutralization Tests | Cathepsin L - metabolism | Phosphatidylinositol 3-Kinases - metabolism | Virus Internalization | Betacoronavirus - immunology | COVID-19 | Cell Fusion | Endocytosis | SARS-CoV-2 | Betacoronavirus - chemistry | Betacoronavirus - physiology | HEK293 Cells | Peptidyl-Dipeptidase A - metabolism | Giant Cells - physiology | Protein Domains | Spike Glycoprotein, Coronavirus - immunology | Cathepsins - antagonists & inhibitors | Spike Glycoprotein, Coronavirus - metabolism | Trypsin - metabolism | Coronavirus Infections - immunology | Pneumonia, Viral - immunology | Cross Reactions | Angiotensin-Converting Enzyme 2 | Cathepsins - metabolism | Antibodies, Viral - immunology | Spike Glycoprotein, Coronavirus - chemistry | Cathepsin L | Spike protein | Cross-reactivity | Severe acute respiratory syndrome | Viral diseases | Antibodies | Viruses | Glycoproteins | Vaccines | Coronaviruses | Drug development | Angiotensin-converting enzyme 2--ACE2 | Immunosuppressive agents | Severe acute respiratory syndrome coronavirus 2 | Proteins | Angiotensin | Spike glycoprotein | Neutralization | Index Medicus
Journal Article
5.
Full Text
Topoisomerase III-β is required for efficient replication of positive-sense RNA viruses
Antiviral research, ISSN 0166-3542, 10/2020, Volume 182, pp. 104874 - 104874
Positive stranded RNA viruses | SARS-CoV-2 | Host factor | Dengue | Topoisomerase III-ß (TOP3B) | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Virology | Cell Line | Influenza A virus - physiology | DNA Topoisomerases, Type I - metabolism | Yellow fever virus - physiology | Humans | Zika Virus - physiology | RNA Viruses - metabolism | Gene Knockout Techniques | Betacoronavirus - physiology | Dengue Virus - physiology | Ebolavirus - physiology | Virus Replication - physiology | Index Medicus
Journal Article
Virus research, ISSN 0168-1702, 04/2017, Volume 234, pp. 118 - 134
Replication | L protein | Transcription | Bunyavirus | Antivirals | Arenavirus | Life Sciences & Biomedicine | Science & Technology | Virology | RNA Replicase - genetics | Humans | Nucleoproteins - genetics | RNA Replicase - metabolism | Viral Proteins - genetics | Arenaviridae - physiology | Viral Proteins - metabolism | Bunyaviridae - genetics | Bunyaviridae - physiology | Virus Replication | Nucleoproteins - metabolism | Transcription, Genetic | Arenaviridae - genetics | Synthesis | Genetic transcription | RNA | Molecular biology | Public health | Antiviral agents | Lassa fever | Hemorrhagic fever | Severe acute respiratory syndrome | Genes | Genomics | Genetic research | HIV (Viruses) | Health aspects | Index Medicus | Biotechnology | Nucleoproteins | Neurons and Cognition | Neurobiology | Innate immunity | Viral Proteins | Emerging diseases | Life Sciences | Immunology | Bunyaviridae | Biomolecules | RNA Replicase | Pharmaceutical sciences | Quantitative Methods | Biochemistry, Molecular Biology | Pharmacology | Bacteriology | Microbiology and Parasitology | Human health and pathology | Infectious diseases | Arenaviridae | JUNV, junin virus | S1P, site 1 protease | sNSV, segmented negative stranded viruses | EM, electron microscopy | wt, wild type | RNP, ribonucleoprotein | FDA, United States Food and Drug Administration | LACV, la crosse virus | aa, amino acid | OTU, ovarian tumour | SSP, stable signal peptide | HFRS, hemorrhagic fever with renal syndrome | HIV, human immunodeficiency virus | MACV, machupo virus | UTR, untranslated regions | SARS, severe acute respiratory syndrome | BUNV, bunyamwera virus | GPC, glycoprotein precursor | LASV, lassa virus | SFTSV, severe fever with thrombocytopenia syndrome virus | Rib, ribavirin | dsRNA, double stranded RNA | OW, old world | CCHFV, crimean congo hemorrhagic fever virus | RdRpol, RNA dependent RNA polymerase | NSV, negative strand virus | EN, endonuclease | IFN-I, type I interferon | RING, really interesting new gene | siRNA, silencing RNA | PDL-1, programmed death-ligand − 1 | NP, nucleoprotein | vRNA, genomic negative sense viral RNA | nsNSV, non-segmented negative stranded virus | MG, mini genome | cRNA, complementary positive sense viral RNA | NW, new world | IGR, intergenic region | ORF, open reading frame | PIV3, parainfluenza virus 3 | HF, hemorrhagic fever | MHC, major histocompatibility complex | RVFV, rift valley fever virus | NCR, non-coding regions | LF, lassa fever | LCMV, lymphocytic choriomeningitis virus
Journal Article